US OptionsDetailed Quotes
EBS241220C8000
- 2.18
- 0.000.00%
15min DelayClose Dec 16 16:00 ET
0.00High0.00Low
2.18Open2.18Pre Close0 Volume1 Open Interest8.00Strike Price0.00Turnover533.70%IV14.77%PremiumDec 20, 2024Expiry Date0.87Intrinsic Value100Multiplier3DDays to Expiry1.31Extrinsic Value100Contract SizeAmericanOptions Type0.6767Delta0.0788Gamma4.07Leverage Ratio-0.2639Theta0.0004Rho2.75Eff Leverage0.0031Vega
Emergent BioSolutions Stock Discussion
Sign in to post a comment
$Tenaya Therapeutics (TNYA.US)$ Trial data on hypertrophic cardiomyopathy (HCM) at 8AM ET. Large float. SI 25.47%. COH $129.9M good for 16.2 months
$Biomea Fusion (BMEA.US)$ Covalent III Trial regarding Type 2 Diabetes mellitus out tomorrow 8AM ET. SI 44.16%. COH $62.4M good for 6.2 months
$Sidus Space (SIDU.US)$ Satellite launch Friday. May continue until launch. Low float. 0 shares LTB.COH $4.8M good for 4.2 months
$Maison Solutions (MSS.US)$...
$Biomea Fusion (BMEA.US)$ Covalent III Trial regarding Type 2 Diabetes mellitus out tomorrow 8AM ET. SI 44.16%. COH $62.4M good for 6.2 months
$Sidus Space (SIDU.US)$ Satellite launch Friday. May continue until launch. Low float. 0 shares LTB.COH $4.8M good for 4.2 months
$Maison Solutions (MSS.US)$...
31
1
8
$Emergent BioSolutions (EBS.US)$
Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
Emergent BioSolutions (NYSE: EBS) has received a $50 million contract option from BARDA for its CYFENDUS® anthrax vaccine. The deliveries are scheduled between now and April 2025. This follows a previous $30 million contract modification for the same vaccine. CYFENDUS®, FDA-approved in July 2023, is a two-dose anthrax vacci...
Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
Emergent BioSolutions (NYSE: EBS) has received a $50 million contract option from BARDA for its CYFENDUS® anthrax vaccine. The deliveries are scheduled between now and April 2025. This follows a previous $30 million contract modification for the same vaccine. CYFENDUS®, FDA-approved in July 2023, is a two-dose anthrax vacci...
$Emergent BioSolutions (EBS.US)$ Reuters
Just
Emergent BioSolutions Receives $50 Million Contract Option From Barda to Procure Doses of Cyfendus® (Anthrax Vaccine Adsorbed, Adjuvanted
Emergent BioSolutions Inc - Cyfendus Vaccine Deliveries Expected to Complete by April 2025
Just
Emergent BioSolutions Receives $50 Million Contract Option From Barda to Procure Doses of Cyfendus® (Anthrax Vaccine Adsorbed, Adjuvanted
Emergent BioSolutions Inc - Cyfendus Vaccine Deliveries Expected to Complete by April 2025
$Emergent BioSolutions (EBS.US)$ 👈 this small float is the maker of narcan the drug that saves lives from opioid overdoses. Huge in the United States because of the cartels pushing fentanyl all over killing everyone.Hit them with narcan it's already saved countless lives. States are starting to require they have some on hand in schools. narcan will be sold all over in every pharmacy, sold to schools , jails, hospitals etc....only one thing like it but doesn't work on fentanyl like narcan does. N...
$Emergent BioSolutions (EBS.US)$ buying back in ... BlackRock, vanguard purposely push assets down. this company has far too many good things happening with new CEO turning things around starting past year. it's bottomed out earlier this year guess who are the ones pushing it down.... they are the ones wanting to buy in cheaper
$Synopsys (SNPS.US)$ $Futu Holdings Ltd (FUTU.US)$ $IonQ Inc (IONQ.US)$
$Synopsys (SNPS.US)$ $Futu Holdings Ltd (FUTU.US)$ $IonQ Inc (IONQ.US)$
8
$Emergent BioSolutions (EBS.US)$ why keep dipping??
1
$Emergent BioSolutions (EBS.US)$ revival please!
$Emergent BioSolutions (EBS.US)$First U.S. mpox case linked to African outbreak detected" data-render="ssr
1
1
No comment yet
lucky Hugh :![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")